We are live on
!
Find out more
PCM
Poehling Capital Management Portfolio holdings
AUM
$466M
1-Year Est. Return
24.17%
This Fund
S&P 500
This Quarter
Est. Return
+5.82%
1 Year Est. Return
+24.17%
3 Year Est. Return
+70.93%
5 Year Est. Return
+69.6%
10 Year Est. Return
–
AUM
$314M
AUM Growth
+$28.3M
(+9.9%)
Cap. Flow
+$12.9M
Cap. Flow
% of AUM
4.11%
Top 10 Holdings %
Top 10 Hldgs %
27.83%
Holding
166
New
9
Increased
51
Reduced
52
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$5.28M |
| 2 |
Organon & Co
OGN
|
+$4M |
| 3 |
Warner Bros
WBD
|
+$3.1M |
| 4 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$2.99M |
| 5 |
Alibaba
BABA
|
+$2.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Ultra Silver
AGQ
|
+$2.7M |
| 2 |
AB InBev
BUD
|
+$2.19M |
| 3 |
WPP
WPP
|
+$1.86M |
| 4 |
PepsiCo
PEP
|
+$1.36M |
| 5 |
Harley-Davidson
HOG
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 35.03% |
| 2 | Healthcare | 13.01% |
| 3 | Communication Services | 10.28% |
| 4 | Technology | 8.87% |
| 5 | Consumer Discretionary | 6.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARA
26
DELISTED
Paramount Global Class B
PARA
| $3.83M | 1.22% |
84,614
+58,336
| +222% | +$2.41M |
|
|
27
Organon & Co
OGN
$3.57B
| $3.68M | 1.17% |
+121,470
| New | +$4M |
|
|
RTN
28
DELISTED
Raytheon Company
RTN
| $3.67M | 1.17% |
43,071
-69
| -0.2% | -$5.89K |
|
29
Loews
L
$23.6B
| $3.61M | 1.15% |
66,067
-823
| -1% | -$46.1K |
|
30
Merck
MRK
$318B
| $3.5M | 1.12% |
45,050
-405
| -0.9% | -$30.1K |
|
31
JPMorgan Chase
JPM
$950B
| $3.48M | 1.11% |
22,393
-118
| -0.5% | -$18.5K |
|
32
Intel
INTC
$513B
| $3.44M | 1.09% |
61,178
+10,347
| +20% | +$607K |
|
33
Altria Group
MO
$114B
| $3.38M | 1.07% |
70,790
-1,932
| -3% | -$94.9K |
|
|
34
Alibaba
BABA
$308B
| $3.26M | 1.04% |
14,387
+13,457
| +1,447% | +$2.99M |
|
35
GraniteShares Gold Shares
BAR
$1.46B
| $3.23M | 1.03% |
183,615
+9,768
| +6% | +$176K |
|
36
Carlyle Group
CG
$17.2B
| $3.23M | 1.03% |
69,389
-981
| -1% | -$41.7K |
|
37
State Street Financial Select Sector SPDR ETF
XLF
$58.2B
| $3.2M | 1.02% |
87,181
-1,232
| -1% | -$45.1K |
|
38
Pfizer
PFE
$153B
| $3.19M | 1.01% |
81,369
+529
| +0.7% | +$20.6K |
|
39
BP
BP
$107B
| $2.98M | 0.95% |
112,773
+1,168
| +1% | +$30.6K |
|
|
RBAC
40
DELISTED
RedBall Acquisition Corp.
RBAC
| $2.79M | 0.89% |
285,266
-13,633
| -5% | -$135K |
|
41
American International
AIG
$41.3B
| $2.78M | 0.88% |
58,314
-127
| -0.2% | -$6.28K |
|
|
42
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$147M
| $2.76M | 0.88% |
5,860
+5,020
| +598% | +$2.99M |
|
43
Bausch Health
BHC
$2.34B
| $2.66M | 0.85% |
90,706
+1,834
| +2% | +$55.6K |
|
44
Bank of America
BAC
$442B
| $2.65M | 0.84% |
64,251
-324
| -0.5% | -$13.3K |
|
|
WPF.U
45
DELISTED
Foley Trasimene Acquisition Corp.
WPF.U
| $2.59M | 0.82% |
246,499
-6,232
| -2% | -$67K |
|
|
BNY
46
Bank of New York Mellon
BNY
$107B
| $2.55M | 0.81% |
49,847
+1,607
| +3% | +$80.4K |
|
47
Johnson & Johnson
JNJ
$625B
| $2.53M | 0.8% |
15,336
+36
| +0.2% | +$5.96K |
|
48
Affiliated Managers Group
AMG
$9.76B
| $2.52M | 0.8% |
16,336
-102
| -0.6% | -$16.3K |
|
49
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $2.48M | 0.79% |
89,364
-106
| -0.1% | -$2.95K |
|
50
Enbridge
ENB
$112B
| $2.45M | 0.78% |
61,136
+848
| +1% | +$32.8K |
|
Similar funds
UC
JHC
HP
ACGA
PC
VCM
SP
LN
Poehling Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Poehling Capital Management held 166 positions worth $314M, up 9.9% from $286M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Poehling Capital Management deployed $12.9M of net new capital in Q2 2021, opening 9 new positions and adding to 51 existing holdings. Its largest new stake was Organon & Co: 121,470 shares worth $3.68M.
By sector, the portfolio is most concentrated in Financials at 35% of assets, down from 35% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was PepsiCo, an estimated $1.36M trimmed.
- Poehling Capital Management's largest Q2 2021 buy was Organon & Co: 121,470 shares worth $3.68M.
- Poehling Capital Management added most to Apple in Q2 2021, an estimated $5.28M increase.
- Poehling Capital Management's biggest Q2 2021 reduction was PepsiCo, cutting an estimated $1.36M.
- Poehling Capital Management fully exited ProShares Ultra Silver in Q2 2021, selling an estimated $2.7M.
- Poehling Capital Management's ten largest holdings make up 28% of its $314M portfolio in Q2 2021.
- Poehling Capital Management opened 9 new positions and closed 18 in Q2 2021.
- Poehling Capital Management's portfolio value rose 9.9% quarter-over-quarter to $314M.
Based on Poehling Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.